(Q40002468)

16 September 2017

title

Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells (English)

1 reference

16 September 2017

0 references

R Wang

1 reference

16 September 2017

F Lin

1 reference

16 September 2017

X Wang

1 reference

16 September 2017

P Gao

1 reference

16 September 2017

K Dong

1 reference

16 September 2017

A-M Zou

1 reference

16 September 2017

S-Y Cheng

1 reference

16 September 2017

S-H Wei

1 reference

16 September 2017

H-Z Zhang

1 reference

16 September 2017

publication date

14 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

402-412

1 reference

Livin, a novel inhibitor of apoptosis protein family member

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

KIAP, a novel member of the inhibitor of apoptosis protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The therapeutic potential of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Specific interference with gene function by double-stranded RNA in early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The silent treatment: siRNAs as small molecule drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The inhibitors of apoptosis: there is more to life than Bcl2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Livin/ML-IAP as a new target for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.16

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2008.16

1 reference

Dimensions Publication ID

16 September 2017

1050728777

0 references

1 reference